Overview

DEBOXA for Inoperable NET Liver Metastases

Status:
Recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

A prospective clinical trial to study the safety and effectiveness of Transcatheter Artery Chemotherapy and Embolization (TACE) using CalliSpheres Drug-Eluting Beads with oxaliplatin (DEBOXA) in treating patients who have inoperable neuroendocrine neoplasm (NEN) liver metastases.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Xiangya Hospital of Central South University

Treatments:

Oxaliplatin